No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls.

ABSTRACT: New ELISA assays were developed to measure immunoreactivity for XMRV. Antibody titers were measured in a cohort of prostate cancer cases and cancer free controls from the central United States. No statistically significant differences were observed in immunoreactivity between cases and controls for either the XMRV-env or the XMRV-gag antigen.

SUBMITTER: Sabunciyan S 

PROVIDER: S-EPMC3285460 | biostudies-literature | 2011 Apr-Jun

REPOSITORIES: biostudies-literature